Kazumasa Fujitani - Concepedia

Author

Kazumasa Fujitani

Also Known As

Akiko Fukui, F Kazumasa, Fujitani Kazumasa, K Fujitani, K. Fujitani, KAZUMASA FUJITANI, Kazumasa FUJITANI, Kazumasa Fujitani, the Osaka Gastrointestinal Cancer Chemotherapy Study Group

421

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Osaka National Hospital Osaka Prefectural Medical Center The University of Osaka Osaka International Cancer Institute Kindai University

About

Kazumasa Fujitani is an author at Osaka National Hospital specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	53	4K
2	Health Sciences	5	5	906
3	Public Health	2	2	288
4	Language Studies	1	1	13
5	Classics	1	1	13

Kazumasa Fujitani

109

Publications

Citations

H-Index

Page 1

	Year	Citations
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial Kazumasa Fujitani, Han‐Kwang Yang, Junki Mizusawa, The Lancet Oncology Single Non-curable FactorSurgical OncologyGastrointestinal OncologyAdvanced Gastric CancerMedicine	2016	688
Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui, Journal of Clinical Oncology	2013	548
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial Kohei Shitara, Toshihiko Doi, Mikhail Dvorkin, The Lancet Oncology Gastrointestinal OncologyTrifluridine/tipiracil Versus PlaceboMedicineMetronomic TherapyGastroenterology	2018	495
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma Takeshi Sano, Mitsuru Sasako, Junki Mizusawa, Annals of Surgery	2016	324
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections Yasunari Fukuda, Kazuyoshi Yamamoto, Motohiro Hirao, Annals of Surgical Oncology MalnutritionNutritionBariatric SurgerySurgical Site InfectionsClinical Nutrition	2015	261
Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer Kazuyoshi Yamamoto, Yukiko Nagatsuma, Yasunari Fukuda, Gastric Cancer NutritionBariatric SurgeryOncologyGeriatricsExercise Physiology	2016	245
Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy Yasunari Fukuda, Kazuyoshi Yamamoto, Motohiro Hirao, Gastric Cancer Surgical OncologyGastrointestinal OncologyGastroenterologySevere Postoperative ComplicationsSurgery	2015	238
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer Takaki Yoshikawa, Mitsuru Sasako, Seiichiro Yamamoto, British journal of surgery	2009	236
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani, The Lancet. Gastroenterology & hepatology Gastrointestinal OncologyMedicineAdvanced Gastric CancerPharmacologyClinical Trials	2017	215

Page 1